In addition, N4BP2L1 has been shown to affect the insulin signaling pathway (Watanabe et al., 2021), consistent with the role of IGF2 expression in the pathophysiology of ACC (Pereira et al., 2019). The gene discussed is N4BP2L1; the disease is adrenal cortex carcinoma.